Irf5 degraders and uses thereof
TW202635650APending Publication Date: 2026-09-01KYMERA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115101495
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2026-01-09
- Filing Date
- 2026-01-14
- Publication Date
- 2026-09-01
Abstract
This disclosure provides compounds and compositions that can be used to regulate interferon regulatory factor 5 ("IRF5") protein via ubiquitination and / or degradation, as well as methods of using such compounds and compositions to treat diseases. The present disclosure provides compounds and compositions useful for the modulation of interferon regulatory factor 5 ("IRF5") protein via ubiquitination and / or degradation, as well as methods of using the same for treating diseases.
Need to check novelty before this filing date? Find Prior Art